Việt Nam News

Media-OutReach Newswire

The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration

Media-OutReach Newswire

Application for clinical trial of AIM Vaccine’s human diploid rabies vaccine

Media-OutReach Newswire

AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval

Media-OutReach Newswire

Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals

Media-OutReach Newswire

The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward

Media-OutReach Newswire

AIM Vaccine Announces 2023 Annual Results

Society

VN strengthens prevention and control of animal-transmitted diseases

Media-OutReach Newswire

AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine

Talk Around Town

Dog owners must have sense of community responsibility

Society

PM emphasises strict rabies prevention and control

Society

Hà Nội takes proactive measures against rabies and whooping cough

Media-OutReach Newswire

AIM Vaccine Enters the Period of Explosive Growth in Major Single Products

Society

Health ministry officially downgrades COVID-19 to Class B disease

Life & Style

Increasing recorded incidence of the “zombie disease” Rabies, in Việt Nam

Society

Experts warn of increasing rabies risk - and how to treat bites

Society

Rabies vaccinations on the rise in HCM City

Media-OutReach Newswire

YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility from European Union GMP

Society

Joints efforts to help Việt Nam to eliminate dog-transmitted rabies deaths by 2030

Life & Style

Health tips for your first visit to Việt Nam

Media-OutReach Newswire

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D